Seizure was first published in March 1992. It was established by Tim Betts, an enthusiastic teacher and neuropsychiatrist from Birmingham, UK, and Brian Chappell, then Director of Information & Training at the British Epilepsy Association (an organisation which has since become Epilepsy Action). In 1996 Seizure acquired the subtitle 'European Journal of Epilepsy', to communicate its international reach and aspirations. More recently, Seizure has become a firmly established epilepsy journal under the editorship of Paul Boon and Albert Aldenkamp. My appointment as Editor-inChief in 2011 marks an opportunity to take stock and formulate plans for the future of the journal.
Twenty years ago, Seizure filled a clear gap in the publishing landscape: whilst Epilepsia would accept submissions focussing on clinical and psychosocial aspects of epilepsy or articles about paroxysmal disorders which might be mistaken for epilepsy, its broad topical remit meant that such publications had to compete with papers about advances in the basic sciences relating to epilepsy. No journal at this time explicitly focused on clinical and psychosocial aspects of seizure disorders or sought to publish research about non-epileptic attack disorders.
Since then, the list of journals, which aspiring authors in this field can chose from, has grown considerably. However, the facts that the outlets available for publications and the quantity of papers about clinical and psychosocial aspects of seizures disorders have multiplied over the last two decades does not mean that Seizure's work is done. It may now be easier to 'get published', but too often, the quality of the work in these particular domains of academic pursuit has lagged behind the quantity of publications. This is reflected by the recent reduction of the impact factor of all journals in this field, which suggests that much of the work published goes unnoticed by others working in the same specialities and by researchers in other branches of medicine or science. This is likely to mean that patients fail to benefit optimally from some advances in the understanding of their disorders.
One of Seizure's jobs for the future is therefore to help drive up research standards, so that it becomes more difficult for clinicians, other researchers, funding bodies and healthcare policy makers to ignore the work published in this journal. Seizure will not address this task simply by rejecting all but those submissions likely to garner the highest number of citations. We will also try to engage authors of submissions which can be improved in a constructive dialogue with the aim of optimising the impact of their work.
A second job for Seizure is better to tap into the currently underused research potential of health professionals who have traditionally not contributed much to the scientific narrative of progress in this area (such as specialist nurses, allied health professionals, people working for epilepsy organisations, healthcare managers, educationalists) and, as importantly, into the rapidly growing research communities in developing countries, especially in East and South East Asia. Seizure will tackle this job by reshaping its editorial team (including the editorial board). The changes to the editorial arrangements will reduce the size of the (real or perceived) communication gap between Editor-in-Chief and potential authors. This will put Seizure in a better position to help authors whenever possible.
A third job for Seizure is to improve the flow of knowledge about epilepsy and other seizure disorders to and from patients (and the wider 'lay' community). Patient and public involvement has recently become such a key aspect of research practice in English speaking countries that it has acquired an acronym -PPI. At a time when politicians, public servants, businessmen and clinicians are increasingly expected to be able to account for their work and actions, the pressure for more and better PPI is bound to increase. Given that all of the papers published in Seizure are essentially about improving the lives of people with paroxysmal neurological disorders, this is a development which we should cherish and embrace. Seizure is particularly well placed to address this task. It is owned by Epilepsy Action, the largest membership-led epilepsy organisation in the United Kingdom, and one of the biggest such organisations in the world. Epilepsy Action has half a century of experience with the communication of knowledge to people with epilepsy and other 'lay' audiences. Its telephone helpline and advice services deal with nearly 14,000 requests for help each year, its website attracts over one million visits per year from around the globe. In collaboration with 'lay' volunteers and supported by Epilepsy Action staff, Seizure will launch a new section of the Epilepsy Action website aimed at patients and other nonhealthcare professionals. Without increasing the work of authors, this website will reach out to a wider audience for the content of the journal and increase the impact which papers published in Seizure have in the real world. I believe that this site will become an important reason why authors chose to publish their work in Seizure. Patients and researchers (but also society at large) are likely to benefit from an improved flow of information: patients will learn more rapidly about new diagnostic techniques and treatments. Their improved understanding will enable them to ask their physicians the right questions. Authors will learn what issues are most relevant to patients. Publishing in Seizure will help those researchers who already have to demonstrate PPI in their work. As for society at large, nothing is likely to reduce stigma and increase opportunities for people with seizures quite as much as better knowledge and understanding. From January 2012 onwards, the new cover of Seizure including artwork produced by a group of artists based at Lydda House at the Bethel Epilepsy Centre in Bielefeld, Germany, will communicate Seizure's aim to facilitate and enrich communication between people with seizures and the research community.
Seizure will continue to provide an international forum for the publication of papers on all topics related to epilepsy and other seizure disorders. These topics include the basic sciences related to the condition itself, the differential diagnosis, natural history and epidemiology of seizures, and the investigation and practical management of seizure disorders (including drug treatment, neurosurgery and non-medical and behavioural treatments). The journal will have a particular focus on clinical aspects and on the social, psychological and educational impact of seizures on the person who experiences them, their family and society. Seizure publishes articles on topics relating to patients of all ages. Basic science research will be 'in scope' if the work addresses important clinical or behavioural questions.
Seizure has come of age, but it is not aging. I greatly look forward to the exciting work, which will come my way as the new Editorin-Chief of this journal.
Markus Reuber Editor-in-Chief
